Breast Cancer Clinical Trial
Official title:
Promoting Breast Cancer Screening in Non-adherent Women
This randomized study compares the effectiveness and cost-effectiveness of 3 proven methods
of reaching out to women who are coming due for or who are overdue for a mammogram. The
study originally embedded in a community healthcare plan and an associated community clinic,
now accepts patients using the community clinic and 3 other health care plans. The study
makes use of a complex computer driven reminder system.
The study also will examine ways to improve the efficiency and sequencing of the
interventions by identifying patient factors associated with intervention effectiveness.
The randomized study compares three interventions. All eligible women are randomly assigned
to 1 of 3 interventions. If they become 18 or more months from a prior mammogram, they will
receive the intervention to which they were assigned.
The 3 arms are
1. RL ARM: (reminder letter) a control arm which consists of a reminder letter only that
states when the last mammogram was, contains a standard recommendation from her primary
care provider (PCP), and requests that the woman call a special number for help
scheduling a mammogram.
2. RC ARM: (reminder call) a reminder letter as above, followed, if no response, by a
reminder call from a study scheduler who offers to help schedule a mammogram.
3. ETTC ARM: (enhanced tailored telephone counseling call) a reminder letter as above,
followed, if no response by a second letter, a mammography educational booklet and a
second request to call a special number to schedule a mammogram. If no response, a
study counselor/educator will call.
A complex computer-based tracking system identifies women coming due for a mammogram or
those overdue for a mammogram. The system interfaces with the clinic database systems and
stores information re age, telephone number, address, prior screening dates, primary care
provider name, scheduling dates, etc. The system can generate reminder letters as
appropriate.
The tracking system also interfaces with computer-assisted telephone script systems(CATI)
which prompt the study scheduler or the study counselor to follow the protocol that is
tailored to the individual patient.
The CATI system captures data from all calls, including how ready a woman is to schedule,
the answers to a brief socio-demographic survey and in the counselor call script barriers
and misinformation about mammography.
The computer system also interfaces with the radiology scheduling system so that study
personnel can assist women in scheduling a mammogram during the phone call.
The primary outcome is the number of women in each arm getting a mammogram. This data will
come from the clinic data base and the healthcare plan billing system.
Secondary outcomes include evaluation of the effect of booster or repeat interventions in
women failing to respond to prior request for mammogram.
;
Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 |